Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Lieu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Expert Opinion on Therapeutic Targets|February 1, 2019
GRK2 and GRK5 as therapeutic targets and their role in maladaptive and pathological cardiac hypertrophyMelissa Lieu, Walter J Koch
PPAR Research|December 30, 2015
PPARs: Protectors or Opponents of Myocardial Function?Christine J Pol, Melissa Lieu, Konstantinos Drosatos
Science Signaling|March 27, 2016
A peptide of the RGS domain of GRK2 binds and inhibits Gα(q) to suppress pathological cardiac hypertrophy and dysfunctionSarah M Schumacher, Erhe Gao, Maya Cohen, et al.
Frontiers in Cardiovascular Medicine|May 8, 2026
miR-181a post-transcriptionally targets GRK2 to limit maladaptive signaling in cardiomyocytesHeidi Cho, Melissa Lieu, Erhe Gao, et al.
Science Signaling|March 31, 2021
A peptide of the N terminus of GRK5 attenuates pressure-overload hypertrophy and heart failureRyan C Coleman, Akito Eguchi, Melissa Lieu, et al.
The Journal of Investigative Dermatology|October 26, 2013
SECTM1 produced by tumor cells attracts human monocytes via CD7-mediated activation of the PI3K pathwayTao Wang, Yingbin Ge, Min Xiao, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 29, 2020
Loss of dynamic regulation of G protein-coupled receptor kinase 2 by nitric oxide leads to cardiovascular dysfunction with agingMelissa Lieu, Christopher J Traynham, Claudio de Lucia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2015
BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor GrowthTao Wang, Min Xiao, Yingbin Ge, et al.
JCI Insight|August 22, 2024
NAD+ precursors prolong survival and improve cardiac phenotypes in a mouse model of Friedreich's AtaxiaCaroline E Perry, Sarah M Halawani, Sarmistha Mukherjee, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Targets|February 1, 2019
GRK2 and GRK5 as therapeutic targets and their role in maladaptive and pathological cardiac hypertrophyMelissa Lieu, Walter J Koch
PPAR Research|December 30, 2015
PPARs: Protectors or Opponents of Myocardial Function?Christine J Pol, Melissa Lieu, Konstantinos Drosatos
Science Signaling|March 27, 2016
A peptide of the RGS domain of GRK2 binds and inhibits Gα(q) to suppress pathological cardiac hypertrophy and dysfunctionSarah M Schumacher, Erhe Gao, Maya Cohen, et al.
Frontiers in Cardiovascular Medicine|May 8, 2026
miR-181a post-transcriptionally targets GRK2 to limit maladaptive signaling in cardiomyocytesHeidi Cho, Melissa Lieu, Erhe Gao, et al.
Science Signaling|March 31, 2021
A peptide of the N terminus of GRK5 attenuates pressure-overload hypertrophy and heart failureRyan C Coleman, Akito Eguchi, Melissa Lieu, et al.
The Journal of Investigative Dermatology|October 26, 2013
SECTM1 produced by tumor cells attracts human monocytes via CD7-mediated activation of the PI3K pathwayTao Wang, Yingbin Ge, Min Xiao, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 29, 2020
Loss of dynamic regulation of G protein-coupled receptor kinase 2 by nitric oxide leads to cardiovascular dysfunction with agingMelissa Lieu, Christopher J Traynham, Claudio de Lucia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2015
BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor GrowthTao Wang, Min Xiao, Yingbin Ge, et al.
JCI Insight|August 22, 2024
NAD+ precursors prolong survival and improve cardiac phenotypes in a mouse model of Friedreich's AtaxiaCaroline E Perry, Sarah M Halawani, Sarmistha Mukherjee, et al.
Pageof 1